Dr Ruth Laibon Masha, PhD, EBS�Chief Executive Officer��National Syndemic Diseases Control Council�Kenya
From Boutique to systemic and sustainable scale up:
The case of HIV prevention
The HIV Response …
2
The Programmes within HIV prevention response operate in siloes
The prevention programme predominantly focuses on biomedical solutions
The prevention programme is highly dependent on donors.
The prevention programme needs innovation and scale up
01
02
03
04
Challenges
Systemic challenges
Translating the thinking differently into doing differently..
Thinking differently…
From national to County clusters
High, Medium, Low incidence cluster
Timely data on granularity of epidemics
Timely incidence surveillance
From interventions to populations
By age group
By priority populations
By bridging populations
From biomedical only to combination prevention
targeted packages at scale
faster research to policy translation
coordinated R&D for HIV prevention
From health to HIV prevention as everyone's business
Leverage political leadership
Leverage social movements
Legal and structural reforms
Who needs HIV Prevention? (populations)
What do they need?
(risk, perceptions)
What is available?
(evidence-based interventions)
How will it be delivered?
(packaging, settings, delivery)
What will it cost?
(cost, effectiveness)
People Living with HIV in Kenya (2013)
Differentiation of sub-populations (2013)
Sub-national level heterogenous (2013)
Data for decision making
Rationale …..
Saves lives
Saves Money
By 2030
1,149,000 new HIV infections &
761,000 AIDS-related deaths
11,000 children deaths
will be averted at no extra cost
New HIV infections reduced by 78.2% in the last decade from 101, 448 in 2013 to 22,154 in 2022
2013
2015
2018
2019
2020
2021
52,800
41,416
34,540
101,448
77,647
32,027
2022
22,154
Source: HIV Estimates 2023
HIV situation in 2022
1,377,784
Kenyans living with HIV in 2023
67,869
Children (0-14 years) living with HIV in 2023
2.6%
5.3%
National HIV prevalence is 3.7%
18,473
AIDS-related deaths 2022
Country | No. of PLHIV |
Kisumu | 128,091 |
Nairobi (County) | 124,609 |
Homa Bay | 120,600 |
Siaya | 96,297 |
Migori | 76,053 |
Nakuru | 57,635 |
Mombasa | 50,656 |
Kakamega | 48,733 |
Kiambu | 45,917 |
Kisii | 42, 210 |
In 2022
57%
of people living with HIV were in
10
Counties
18.3%
HIV PREVALENCE AMONG KEY POPULATIONS
22,154
New HIV Infections
4,474
12,558
5,122
Children aged 0-14
Women
Men
Source: Kenya HIV Estimates 2023
Kenya Demographic Health Survey 2022
Kenya Health Information Systems 2023
New HIV infections
41%
Adult new HIV infection occur among Adolescents and Young People aged 15-24 years
What have we learnt?
Strategy 1: Apply a precision and differentiated HIV prevention approach based on incidence, prevalence, and changing epidemic typology in the geography ��
“Concentrated” epidemic in
22 counties
“Generalizing” epidemic in
4 counties
“Mixed” epidemic in
21 counties
Concentrated
Key Populations
Mixed
Adolescent and young people
Key Populations
Pregnant and lactating women and children
Pregnant and lactating women and children
PLHIV
Generalizing
Vulnerable populations and other networks
Adolescent and young people
Key Populations
Pregnant and lactating women and children
PLHIV
Establishment and application of Baseline data (IBBS 2011)
2011-2012
Development of National Policies, guidelines and standard operating procedures (HIV prevention Revolution Roadmap)
2013-2015
Adoptation and Implementation of combination prevention interventions *Behavioral; Biomedical; Structural)
2016-2018
Start
The National Key Population program was established
2009-2010
Key Population programme scale up and quality assurance
2018-2020
Epidemic Appraisal to guide counties response
2021-2023
Sustain effective interventions for key populations
Strategy 2: Develop tools to measure quality, coverage and impact of interventions to address coverage and utilization gap��
���Strategy 3: Strengthen and expand community-led HIV prevention services���
Strategy 4 ; Integrate HIV prevention by strengthening health systems and leveraging multiple sectors �
a) HIV prevention programs, including PrEP, VMMC, condom promotion, and initiatives targeting specific sub-populations.
b) HIV prevention with other health sector programs, including tuberculosis control, viral hepatitis prevention and care, reproductive, maternal and child health, adolescent health, family planning, and sexually transmitted infection control.
c) With other non-health sectors platforms such as education, gender equity, housing and social protection.
Strategy 5: Improve utilization of programme data
Strategy 5: Invest and prepare for adoption of HIV prevention choices and technology�
1980’s
2030
Scheckter M, 2002
?
Early population-level
successes (late 1980s)
Behavior change (Uganda)
100% Condom use (Thailand)
STI Treatment
Grosskurth, Lancet 2000,
(likely to work mainly in HIV epidemics /sub-populations with high bacterial STIs)
Male & female condoms
Male circumcision
Auvert, PloS Med 2005; Bailey, Lancet 2007; Gray, Lancet 2007
Coates, Lancet 2000
Sweat, Lancet 2011
(effects mostly for persons who test HIV positive and couples)
HIV testing & counselling
Post-exposure prophylaxis
Cohen, NEJM, 2011; Donnell, Lancet 2010; Tanser, Science 2013
Treatment as prevention
Oral �pre-exposure prophylaxis
Grant, NEJM 2010 (MSM)
Baeten, NEJM 2012 (Couples)
Paxton, NEJM 2012 (Heterosex.); Choopanya, Lancet 2013 (PWID)
�Ongoing …..
Carey, 1992
Weller, Cochrane DBS 2002
Hanenberg, Lancet 1994
Stoneburner, Science 2004
Harm reduction
Ljungberg, AIDS 1996
Des Jarlais, Lancet 1996 Hurley, Lancet 1997
Preventing transmission and acquisition of HIV: A timeline
1990’s
2000’s
2020’s
23
Leverage on development synergies …Interventions with proven Impact
– Economic Empowerment of women and girls (IMAGE studies; cash transfer programmes)
– Secondary education for girls and young women
– Community empowerment (sex workers in India)
– Harm reduction policies
Going back to basics
New Kid on the block
24
Strategy 6 : Prioritize prevention funding…..
An analysis of the AIDS Spending Categories (ASC) according to the KNASA report 2022 .
Care and Treatment -51 %
HIV Testing -12 %
Prevention -9%
Social protection and economic support 7%
Research (0.1%).
Prevention progress not fast enough…strategic investments still required….
HIV prevention must be prioritized in funding transitions and sustainability agendas �
Source: KNASA 2022